Solutions for Surrogacy Validation with Longitudinal Outcomes for a Gene Therapy
From MaRDI portal
Publication:6055756
DOI10.1111/biom.13720zbMath1522.62221MaRDI QIDQ6055756
Unnamed Author, Michael R. Elliott
Publication date: 30 October 2023
Published in: Biometrics (Search for Journal in Brave)
surrogate endpointsBayesian methodsprincipal stratificationcrossover designlongitudinal outcomesdelayed-start
Cites Work
- Assessing surrogate endpoints in vaccine trials with case-cohort sampling and the Cox model
- Efficient estimation of covariance selection models
- Surrogate Measures and Consistent Surrogates
- Principal Stratification in Causal Inference
- Validation of Surrogate Markers in Multiple Randomized Clinical Trials with Repeated Measurements: Canonical Correlation Approach
- Evaluating Candidate Principal Surrogate Endpoints
- Validation of a longitudinally measured surrogate marker for a time-to-event endpoint
- Validation of Surrogate Markers in Multiple Randomized Clinical Trials with Repeated Measurements
- A framework for Bayesian nonparametric inference for causal effects of mediation
- Augmented Designs to Assess Immune Response in Vaccine Trials
- Evaluation of longitudinal surrogate markers
- Unnamed Item
- Unnamed Item
This page was built for publication: Solutions for Surrogacy Validation with Longitudinal Outcomes for a Gene Therapy